- Home
- HAE
HAE
Haemonetics Corporation
as 03-28-2025 4:00pm EST
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | N/A | IPO Year: | 1991 |
| Target Price: | $103.11 | AVG Volume (30 days): | 779.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.54 | EPS Growth: | 3.20 |
| 52 Week Low/High: | $58.80 - $97.97 | Next Earning Date: | 05-08-2025 |
| Revenue: | $1,373,515,000 | Revenue Growth: | 8.13% |
| Revenue Growth (this year): | 5.04% | Revenue Growth (next year): | -1.45% |
Latest Haemonetics Corporation News
HAE Breaking Stock News: Dive into HAE Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
HAE: Lowering target price to $67.00
Simply Wall St.
5 days ago
A Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To Equity
Zacks
9 days ago
Medtronic (MDT) Up 5.6% Since Last Earnings Report: Can It Continue?
StockStory
9 days ago
3 Healthcare Stocks Walking a Fine Line
Zacks
11 days ago
Is it Apt to Retain HAE Stock in Your Portfolio for Now?
MT Newswires
11 days ago
Needham Trims Price Target on Haemonetics to $104 From $108, Keeps Buy Rating
StockStory
18 days ago
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers
Argus Research
25 days ago
HAE: What does Argus have to say about HAE?
Compare HAE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HAE Haemonetics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.